Anonymous
Guest
Anonymous
Guest
Will an Onyx field force launch both Blinatumumab and Tvec? Does that mean the Amgen commercial staff on those products will be joining as Onyx employees or will they give those products to current Onyx employees and fire or redistribute current Amgen commercial staff (Global marketing, US Marketing, and Reimbursement and Access).
In case you've been asleep...therapeutic Onc is moving to SSF. So...what do you think is going to happen? Blue team field and H/O have a major product with generic competition on the horizon with a commercial and field team largely inexperienced in therapeutic oncology. All of therapeutic oncology is moving to SSF.